On 16 January, the Governing Board and PARC consortium members are invited to a webinar where findings from two important case studies will be presented: One case study on coordination methods for a ‘one substance, one assessment’ approach, and one on the identification of gaps in the regulation of substances with biocidal properties. These studies demonstrate PARC's ongoing effort to translate scientific research into practical policy insights for chemical risk management.

Towards a unified chemical assessment framework

The first case study examines the fragmented nature of current EU chemical risk assessment frameworks, which are governed by multiple legislations and agencies. This case study evaluates the potential of a coordinated, holistic ‘one substance, one assessment ↗’ approach.

The research focuses on developing methods to streamline risk assessment processes, improve data-sharing between agencies, and reduce regulatory inconsistencies. Outputs include recommendations for harmonising frameworks and addressing cumulative exposures from all uses of the same chemical. Such advances are expected to enhance the efficiency and reliability of chemical risk management across the EU.

Addressing regulatory gaps for biocidal substances

The second case study investigates inconsistencies in the regulation of substances covered by multiple EU legislations, with a focus on biocidal properties. The study assesses overlaps and gaps between key frameworks such as the REACH ↗ Regulation, the Cosmetic Product Regulation ↗, and the CLP Regulation ↗.

By analysing case-specific issues, including new hazard classifications for endocrine disruptors ↗, the study provides recommendations for improving legislative coherence. Its findings aim to strengthen the protection of human health and the environment while ensuring more effective regulation of hazardous substances.

Key takeaways for policy and practice

These case studies contribute directly to PARC’s mission to bridge science and policy, offering actionable solutions to complex regulatory challenges. The webinar will provide an in-depth look at their results and the implications for future regulatory strategies.

We look forward to the outcomes and discussions from this event!